Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH

J. Gregory Cairncross; Meihua Wang; Robert B. Jenkins; Edward G. Shaw; Caterina Giannini; David G. Brachman; Jan C. Buckner; Karen L. Fink; Luis Souhami; Normand J. Laperriere; Jason T. Huse; Minesh P. Mehta; Walter J. Curran

doi:10.1200/JCO.2013.49.3726

Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH

J. Gregory Cairncross, Meihua Wang, Robert B. Jenkins, Edward G. Shaw, Caterina Giannini, David G. Brachman, Jan C. Buckner, Karen L. Fink, Luis Souhami, Normand J. Laperriere, Jason T. Huse, Minesh P. Mehta, Walter J. Curran

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
Volume	32
DOIs	https://doi.org/10.1200/JCO.2013.49.3726
State	Published - Mar 10 2014

Disciplines

Medicine and Health Sciences
Pathology

Access to Document

10.1200/JCO.2013.49.3726License: Unspecified

Cite this

Cairncross, J. G., Wang, M., Jenkins, R. B., Shaw, E. G., Giannini, C., Brachman, D. G., Buckner, J. C., Fink, K. L., Souhami, L., Laperriere, N. J., Huse, J. T., Mehta, M. P., & Curran, W. J. (2014). Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH. Journal of Clinical Oncology, 32. https://doi.org/10.1200/JCO.2013.49.3726

@article{4fe2e56eb8184e369cf4da00e9040c0e,

title = "Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH",

author = "Cairncross, \{J. Gregory\} and Meihua Wang and Jenkins, \{Robert B.\} and Shaw, \{Edward G.\} and Caterina Giannini and Brachman, \{David G.\} and Buckner, \{Jan C.\} and Fink, \{Karen L.\} and Luis Souhami and Laperriere, \{Normand J.\} and Huse, \{Jason T.\} and Mehta, \{Minesh P.\} and Curran, \{Walter J.\}",

note = "In order to access this website, please configure your browser to support cookies.",

year = "2014",

month = mar,

day = "10",

doi = "10.1200/JCO.2013.49.3726",

language = "American English",

volume = "32",

journal = "Journal of Clinical Oncology",

}

TY - JOUR

T1 - Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH

AU - Cairncross, J. Gregory

AU - Wang, Meihua

AU - Jenkins, Robert B.

AU - Shaw, Edward G.

AU - Giannini, Caterina

AU - Brachman, David G.

AU - Buckner, Jan C.

AU - Fink, Karen L.

AU - Souhami, Luis

AU - Laperriere, Normand J.

AU - Huse, Jason T.

AU - Mehta, Minesh P.

AU - Curran, Walter J.

N1 - In order to access this website, please configure your browser to support cookies.

PY - 2014/3/10

Y1 - 2014/3/10

UR - http://ascopubs.org/doi/10.1200/JCO.2013.49.3726

U2 - 10.1200/JCO.2013.49.3726

DO - 10.1200/JCO.2013.49.3726

M3 - Article

VL - 32

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH

Disciplines

Access to Document

Other files and links

Cite this